COc1c2c(cc3c1C1(O)Cc4ccc5c(c4C[N+]1(C)CC3)OCO5)OCO2.[Cl-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?